Colgate-Palmolive (NYSE:CL) Given New $100.00 Price Target at Bank of America

Colgate-Palmolive (NYSE:CL) had its price objective boosted by Bank of America from $90.00 to $100.00 in a research report report published on Monday,Benzinga reports. Bank of America currently has a buy rating on the stock.

Several other analysts have also weighed in on CL. Morgan Stanley raised their price objective on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the stock an “overweight” rating in a report on Monday. UBS Group boosted their target price on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. Raymond James Financial lowered their price objective on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a research report on Monday, October 20th. Jefferies Financial Group set a $85.00 target price on shares of Colgate-Palmolive in a research report on Tuesday, December 16th. Finally, Evercore ISI lowered their price target on shares of Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating for the company in a research report on Monday, November 3rd. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $94.13.

Colgate-Palmolive Trading Up 1.6%

Colgate-Palmolive stock opened at $91.75 on Monday. Colgate-Palmolive has a 12 month low of $74.54 and a 12 month high of $100.18. The stock has a market cap of $73.96 billion, a price-to-earnings ratio of 35.02, a price-to-earnings-growth ratio of 6.09 and a beta of 0.29. The business has a 50 day moving average price of $81.02 and a two-hundred day moving average price of $81.37. The company has a quick ratio of 0.27, a current ratio of 0.42 and a debt-to-equity ratio of 5.90.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.Colgate-Palmolive’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.91 earnings per share. As a group, equities analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 79.39%.

Institutional Investors Weigh In On Colgate-Palmolive

Large investors have recently modified their holdings of the business. Westside Investment Management Inc. grew its position in shares of Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after purchasing an additional 130 shares during the period. Vermillion & White Wealth Management Group LLC lifted its stake in Colgate-Palmolive by 86.1% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after buying an additional 155 shares in the last quarter. Maseco LLP bought a new position in Colgate-Palmolive in the fourth quarter valued at approximately $27,000. Copia Wealth Management acquired a new position in shares of Colgate-Palmolive in the third quarter valued at approximately $29,000. Finally, Cloud Capital Management LLC bought a new stake in shares of Colgate-Palmolive during the third quarter worth $30,000. 80.41% of the stock is currently owned by institutional investors.

Key Stories Impacting Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Large-cap brokers raised targets/ratings — Bank of America moved its target to $100 and kept a Buy rating (about ~9% upside), signaling confidence in the company’s growth drivers. Bank of America raises PT to $100
• Positive Sentiment: Evercore lifted its target to $100 and set an Outperform rating, another high-profile shop adding upside to consensus. Evercore raises PT to $100
• Positive Sentiment: JPMorgan raised its price target to $97 and put CL at Overweight, adding institutional weight behind the post-earnings view. JPMorgan raises PT to $97
• Positive Sentiment: Colgate reported Q4 results that beat estimates (EPS $0.95 vs. $0.91 expected; revenue $5.23B vs. $5.13B expected) and organic sales growth, which prompted analysts to boost forecasts. Earnings strength is the primary catalyst for the upgrades. Analysts Boost Forecasts After Q4 Beat
• Positive Sentiment: Sell-side commentary (TD Cowen, Bank of America research notes) emphasizes premiumization, emerging-market strength and pet nutrition as multi-year growth levers supporting Buy ratings. Analyst thematic support
• Neutral Sentiment: Jefferies raised its target modestly to $91 but keeps a Hold rating; the new target is near the current price, implying limited near-term upside. Jefferies raises PT to $91 (Hold)
• Neutral Sentiment: Deutsche Bank raised its target to $90 and remains a Hold, another signal that some shops see less immediate upside despite the beat. Deutsche Bank raises PT to $90
• Negative Sentiment: Press coverage highlights lingering consumer uncertainty that could pressure volumes/mix going forward, a reminder that macro headwinds remain despite the beat. Consumer uncertainty clouds outlook

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.